Related Experiment Video
Updated: Jun 19, 2026

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
Published on: October 16, 2013
Screening for OST deficiencies in unsolved CDG-I patients
Wendy Vleugels1, Els Schollen, François Foulquier
1Laboratory for Molecular Diagnosis, Center for Human Genetics, University of Leuven, B-3000 Leuven, Belgium.
Abstract:
Congenital Disorders of Glycosylation (CDG) are a group of inherited disorders caused by deficiencies in glycosylation. Since 1980, 14 CDG type I (CDG-I) defects have been identified in the endoplasmic reticulum, all affecting the assembly of the oligosaccharide precursor. However, the number of unsolved CDG-I (CDG-Ix) patients displaying protein hypoglycosylation in combination with an apparently normal assembly of the oligosaccharide precursor is currently expanding. We hypothesized that the hypoglycosylation observed in some of these patients could be caused by a deficiency in the transfer of the oligosaccharide precursor onto protein, a reaction catalyzed by the oligosaccharyltransferase (OST) complex. For this purpose, the different subunits of the OST complex were screened in 27 CDG-Ix patients for whom structural analysis of the lipid-linked oligosaccharides revealed a normal level and intact structure of the oligosaccharide precursor. Among these 27 patients, one was identified with a homozygous missense mutation (c.1121G>A; p.G374D) in the ribophorin 2 (RPN2) subunit of the OST complex. The pathogenic nature of this mutation remains unproven due to the complexity of tackling a possible OST defect.
Insights
Researchers investigated Congenital Disorders of Glycosylation (CDG) and identified a potential cause for unexplained cases. A mutation in the RPN2 gene, part of the oligosaccharyltransferase complex, was found in one patient with unexplained hypoglycosylation.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Congenital Disorders of Glycosylation (CDG) are inherited defects in glycosylation.
- 14 CDG type I (CDG-I) defects affecting oligosaccharide precursor assembly are known.
- An increasing number of CDG-I patients (CDG-Ix) show protein hypoglycosylation without precursor assembly defects.
Purpose of the Study:
- To investigate if oligosaccharyltransferase (OST) complex deficiency causes hypoglycosylation in CDG-Ix patients.
- To screen OST complex subunits in CDG-Ix patients with normal precursor structures.
Main Methods:
- Screening of OST complex subunits in 27 CDG-Ix patients.
- Analysis of lipid-linked oligosaccharide structure and level.
- Genetic analysis for mutations in OST subunits.
Main Results:
- One patient with unexplained hypoglycosylation was identified.
- The patient had a homozygous missense mutation (c.1121G>A; p.G374D) in the RPN2 subunit of the OST complex.
- The mutation's pathogenic nature requires further validation due to OST defect complexities.
Conclusions:
- A potential link between RPN2 mutations and CDG-Ix is suggested.
- This finding highlights the OST complex as a potential target for diagnosing unexplained CDG.
- Further research is needed to confirm the pathogenicity of the identified RPN2 mutation.
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
